Project
Illumina Body Map 2
Navigation
Downloads
Results for MECP2
Z-value: 2.39
Motif logo
Transcription factors associated with MECP2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MECP2
|
ENSG00000169057.15 | methyl-CpG binding protein 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MECP2 | hg19_v2_chrX_-_153363188_153363212 | -0.14 | 4.6e-01 | Click! |
Activity profile of MECP2 motif
Sorted Z-values of MECP2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_2050852 | 4.20 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr7_-_139477500 | 3.97 |
ENST00000406875.3
ENST00000428878.2 |
HIPK2
|
homeodomain interacting protein kinase 2 |
| chr10_+_6186847 | 3.64 |
ENST00000536985.1
ENST00000379789.4 |
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
| chr19_+_35521616 | 3.24 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr20_+_48807351 | 3.22 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
| chr9_+_137218362 | 3.14 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
| chr19_-_33793430 | 3.02 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
| chr9_-_134615326 | 2.97 |
ENST00000438647.1
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1 |
| chr16_+_21610879 | 2.91 |
ENST00000396014.4
|
METTL9
|
methyltransferase like 9 |
| chr20_+_57466461 | 2.82 |
ENST00000306090.10
|
GNAS
|
GNAS complex locus |
| chr12_+_58148842 | 2.82 |
ENST00000266643.5
|
MARCH9
|
membrane-associated ring finger (C3HC4) 9 |
| chr14_-_24664776 | 2.76 |
ENST00000530468.1
ENST00000528010.1 ENST00000396854.4 ENST00000524835.1 ENST00000261789.4 ENST00000525592.1 |
TM9SF1
|
transmembrane 9 superfamily member 1 |
| chr16_+_85646763 | 2.75 |
ENST00000411612.1
ENST00000253458.7 |
GSE1
|
Gse1 coiled-coil protein |
| chr12_-_54982300 | 2.75 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr17_-_66287310 | 2.71 |
ENST00000582867.1
|
SLC16A6
|
solute carrier family 16, member 6 |
| chr19_+_35521572 | 2.70 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr14_-_24664540 | 2.64 |
ENST00000530563.1
ENST00000528895.1 ENST00000528669.1 ENST00000532632.1 |
TM9SF1
|
transmembrane 9 superfamily member 1 |
| chr6_-_32157947 | 2.61 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
| chr16_+_29817841 | 2.58 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr22_+_46546494 | 2.56 |
ENST00000396000.2
ENST00000262735.5 ENST00000420804.1 |
PPARA
|
peroxisome proliferator-activated receptor alpha |
| chr16_+_85646891 | 2.51 |
ENST00000393243.1
|
GSE1
|
Gse1 coiled-coil protein |
| chr2_-_127864577 | 2.49 |
ENST00000376113.2
|
BIN1
|
bridging integrator 1 |
| chrX_+_109245863 | 2.47 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
| chr2_-_178129551 | 2.43 |
ENST00000430047.1
|
NFE2L2
|
nuclear factor, erythroid 2-like 2 |
| chr2_-_127864839 | 2.41 |
ENST00000409400.1
ENST00000357970.3 ENST00000393040.3 ENST00000348750.4 ENST00000259238.4 ENST00000346226.3 ENST00000393041.3 ENST00000351659.3 ENST00000352848.3 ENST00000316724.5 |
BIN1
|
bridging integrator 1 |
| chr16_+_3096638 | 2.40 |
ENST00000336577.4
|
MMP25
|
matrix metallopeptidase 25 |
| chr12_-_76478446 | 2.38 |
ENST00000393263.3
ENST00000548044.1 ENST00000547704.1 ENST00000431879.3 ENST00000549596.1 ENST00000550934.1 ENST00000551600.1 ENST00000547479.1 ENST00000547773.1 ENST00000544816.1 ENST00000542344.1 ENST00000548273.1 |
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr19_-_913160 | 2.36 |
ENST00000361574.5
ENST00000587975.1 |
R3HDM4
|
R3H domain containing 4 |
| chr17_-_66287350 | 2.36 |
ENST00000580666.1
ENST00000583477.1 |
SLC16A6
|
solute carrier family 16, member 6 |
| chr8_-_141645645 | 2.34 |
ENST00000519980.1
ENST00000220592.5 |
AGO2
|
argonaute RISC catalytic component 2 |
| chr12_-_76478386 | 2.31 |
ENST00000535020.2
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr2_-_235405679 | 2.30 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr8_-_134584092 | 2.28 |
ENST00000522652.1
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
| chr10_+_31608054 | 2.27 |
ENST00000320985.10
ENST00000361642.5 ENST00000560721.2 ENST00000558440.1 ENST00000424869.1 ENST00000542815.3 |
ZEB1
|
zinc finger E-box binding homeobox 1 |
| chr17_-_4890649 | 2.26 |
ENST00000361571.5
|
CAMTA2
|
calmodulin binding transcription activator 2 |
| chrX_-_153714994 | 2.25 |
ENST00000369660.4
|
UBL4A
|
ubiquitin-like 4A |
| chr5_+_149865377 | 2.25 |
ENST00000522491.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
| chr19_+_35521699 | 2.24 |
ENST00000415950.3
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr11_-_1780261 | 2.23 |
ENST00000427721.1
|
RP11-295K3.1
|
RP11-295K3.1 |
| chr1_+_90286562 | 2.21 |
ENST00000525774.1
ENST00000337338.5 |
LRRC8D
|
leucine rich repeat containing 8 family, member D |
| chr7_-_105925367 | 2.20 |
ENST00000354289.4
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr19_+_1286097 | 2.18 |
ENST00000215368.2
|
EFNA2
|
ephrin-A2 |
| chr11_+_117049854 | 2.18 |
ENST00000278951.7
|
SIDT2
|
SID1 transmembrane family, member 2 |
| chr21_-_36262032 | 2.17 |
ENST00000325074.5
ENST00000399237.2 |
RUNX1
|
runt-related transcription factor 1 |
| chr20_-_60718430 | 2.16 |
ENST00000370873.4
ENST00000370858.3 |
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7 |
| chr9_-_134615443 | 2.16 |
ENST00000372195.1
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1 |
| chr15_-_102029873 | 2.15 |
ENST00000348070.1
ENST00000358417.3 ENST00000344273.2 |
PCSK6
|
proprotein convertase subtilisin/kexin type 6 |
| chr2_+_238600788 | 2.15 |
ENST00000289175.6
ENST00000244815.5 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr6_-_166796461 | 2.12 |
ENST00000360961.6
ENST00000341756.6 |
MPC1
|
mitochondrial pyruvate carrier 1 |
| chr1_+_206680879 | 2.11 |
ENST00000355294.4
ENST00000367117.3 |
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
| chr22_-_47134077 | 2.11 |
ENST00000541677.1
ENST00000216264.8 |
CERK
|
ceramide kinase |
| chr4_+_38665810 | 2.10 |
ENST00000261438.5
ENST00000514033.1 |
KLF3
|
Kruppel-like factor 3 (basic) |
| chr9_-_139581848 | 2.10 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr1_+_27153173 | 2.10 |
ENST00000374142.4
|
ZDHHC18
|
zinc finger, DHHC-type containing 18 |
| chr17_+_21188012 | 2.09 |
ENST00000529517.1
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
| chr14_+_75894714 | 2.09 |
ENST00000559060.1
|
JDP2
|
Jun dimerization protein 2 |
| chr13_+_113863858 | 2.08 |
ENST00000375440.4
|
CUL4A
|
cullin 4A |
| chr19_+_1249869 | 2.07 |
ENST00000591446.2
|
MIDN
|
midnolin |
| chr1_-_33815486 | 2.07 |
ENST00000373418.3
|
PHC2
|
polyhomeotic homolog 2 (Drosophila) |
| chr16_-_89724051 | 2.06 |
ENST00000550102.1
|
CHMP1A
|
charged multivesicular body protein 1A |
| chr17_+_75137460 | 2.06 |
ENST00000587820.1
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae) |
| chr18_+_77160282 | 2.04 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
| chr19_-_4723761 | 2.04 |
ENST00000597849.1
ENST00000598800.1 ENST00000602161.1 ENST00000597726.1 ENST00000601130.1 ENST00000262960.9 |
DPP9
|
dipeptidyl-peptidase 9 |
| chr1_-_150947299 | 2.03 |
ENST00000361419.5
|
CERS2
|
ceramide synthase 2 |
| chr1_+_206858328 | 2.03 |
ENST00000367103.3
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
| chr12_-_58131931 | 2.03 |
ENST00000547588.1
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
| chr3_-_113415441 | 2.03 |
ENST00000491165.1
ENST00000316407.4 |
KIAA2018
|
KIAA2018 |
| chr12_-_54071181 | 2.01 |
ENST00000338662.5
|
ATP5G2
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) |
| chr5_-_179285785 | 2.01 |
ENST00000520698.1
ENST00000518235.1 ENST00000376931.2 ENST00000518219.1 ENST00000521333.1 ENST00000523084.1 |
C5orf45
|
chromosome 5 open reading frame 45 |
| chr7_-_105925558 | 2.01 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr7_-_150497406 | 2.00 |
ENST00000492607.1
ENST00000326442.5 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
| chr19_-_42759266 | 1.96 |
ENST00000594664.1
|
AC006486.9
|
Uncharacterized protein |
| chr8_-_134584152 | 1.95 |
ENST00000521180.1
ENST00000517668.1 ENST00000319914.5 |
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
| chr21_-_16437126 | 1.95 |
ENST00000318948.4
|
NRIP1
|
nuclear receptor interacting protein 1 |
| chr16_+_21610797 | 1.93 |
ENST00000358154.3
|
METTL9
|
methyltransferase like 9 |
| chr17_+_21187976 | 1.93 |
ENST00000342679.4
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
| chr11_+_118978045 | 1.93 |
ENST00000336702.3
|
C2CD2L
|
C2CD2-like |
| chr5_-_180229833 | 1.93 |
ENST00000307826.4
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr1_-_33168336 | 1.92 |
ENST00000373484.3
|
SYNC
|
syncoilin, intermediate filament protein |
| chr18_+_77155856 | 1.92 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
| chr1_-_182361327 | 1.92 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
| chr1_+_154378049 | 1.92 |
ENST00000512471.1
|
IL6R
|
interleukin 6 receptor |
| chr7_+_150497491 | 1.90 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
| chr1_+_17866290 | 1.90 |
ENST00000361221.3
ENST00000452522.1 ENST00000434513.1 |
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
| chr22_-_37415475 | 1.89 |
ENST00000403892.3
ENST00000249042.3 ENST00000438203.1 |
TST
|
thiosulfate sulfurtransferase (rhodanese) |
| chr7_-_100493744 | 1.89 |
ENST00000428317.1
ENST00000441605.1 |
ACHE
|
acetylcholinesterase (Yt blood group) |
| chr6_-_160114260 | 1.89 |
ENST00000367054.2
ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr12_+_68042517 | 1.88 |
ENST00000393555.3
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
| chr2_+_238600933 | 1.88 |
ENST00000420665.1
ENST00000392000.4 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr19_-_30206128 | 1.87 |
ENST00000392276.1
ENST00000592153.1 ENST00000323670.9 |
C19orf12
|
chromosome 19 open reading frame 12 |
| chrX_+_48455866 | 1.87 |
ENST00000376729.5
ENST00000218056.5 |
WDR13
|
WD repeat domain 13 |
| chr7_-_105926058 | 1.86 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr19_+_13056663 | 1.86 |
ENST00000541222.1
ENST00000316856.3 ENST00000586534.1 ENST00000592268.1 |
RAD23A
|
RAD23 homolog A (S. cerevisiae) |
| chr4_-_1166623 | 1.86 |
ENST00000290902.5
|
SPON2
|
spondin 2, extracellular matrix protein |
| chr16_+_87425914 | 1.86 |
ENST00000565788.1
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta |
| chr9_+_138392483 | 1.86 |
ENST00000241600.5
|
MRPS2
|
mitochondrial ribosomal protein S2 |
| chr5_-_179233314 | 1.86 |
ENST00000523108.1
|
MGAT4B
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B |
| chr9_-_139440314 | 1.85 |
ENST00000277541.6
|
NOTCH1
|
notch 1 |
| chr15_-_64338521 | 1.84 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
| chr17_+_73083816 | 1.83 |
ENST00000580123.1
ENST00000578847.1 |
SLC16A5
|
solute carrier family 16 (monocarboxylate transporter), member 5 |
| chr16_+_29817399 | 1.83 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr3_-_24536453 | 1.83 |
ENST00000453729.2
ENST00000413780.1 |
THRB
|
thyroid hormone receptor, beta |
| chr22_-_19419205 | 1.83 |
ENST00000340170.4
ENST00000263208.5 |
HIRA
|
histone cell cycle regulator |
| chr1_+_16010779 | 1.80 |
ENST00000375799.3
ENST00000375793.2 |
PLEKHM2
|
pleckstrin homology domain containing, family M (with RUN domain) member 2 |
| chrX_-_21676442 | 1.80 |
ENST00000379499.2
|
KLHL34
|
kelch-like family member 34 |
| chr18_-_28681950 | 1.79 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
| chr17_-_73267304 | 1.79 |
ENST00000579297.1
ENST00000580571.1 |
MIF4GD
|
MIF4G domain containing |
| chr12_+_122459757 | 1.78 |
ENST00000261822.4
|
BCL7A
|
B-cell CLL/lymphoma 7A |
| chr17_+_78965624 | 1.77 |
ENST00000325167.5
|
CHMP6
|
charged multivesicular body protein 6 |
| chr5_-_179285848 | 1.77 |
ENST00000403396.2
ENST00000292586.6 |
C5orf45
|
chromosome 5 open reading frame 45 |
| chr1_+_203274639 | 1.77 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
| chr20_+_35202909 | 1.76 |
ENST00000558530.1
ENST00000558028.1 ENST00000560025.1 |
TGIF2-C20orf24
TGIF2
|
TGIF2-C20orf24 readthrough TGFB-induced factor homeobox 2 |
| chr5_-_179233934 | 1.76 |
ENST00000292591.7
|
MGAT4B
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B |
| chr6_-_160114293 | 1.76 |
ENST00000337404.4
ENST00000538183.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr4_-_36245561 | 1.75 |
ENST00000506189.1
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
| chr15_-_60884706 | 1.75 |
ENST00000449337.2
|
RORA
|
RAR-related orphan receptor A |
| chr9_+_132815985 | 1.75 |
ENST00000372410.3
|
GPR107
|
G protein-coupled receptor 107 |
| chr12_-_76478417 | 1.75 |
ENST00000552342.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr11_+_1968508 | 1.74 |
ENST00000397298.3
ENST00000381519.1 ENST00000397297.3 ENST00000381514.3 ENST00000397294.3 |
MRPL23
|
mitochondrial ribosomal protein L23 |
| chr17_+_78234625 | 1.74 |
ENST00000508628.2
ENST00000582970.1 ENST00000456466.1 ENST00000319921.4 |
RNF213
|
ring finger protein 213 |
| chr2_-_25564750 | 1.74 |
ENST00000321117.5
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
| chr18_-_60987220 | 1.74 |
ENST00000398117.1
|
BCL2
|
B-cell CLL/lymphoma 2 |
| chr20_-_39317868 | 1.73 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
| chr8_-_131028641 | 1.73 |
ENST00000523509.1
|
FAM49B
|
family with sequence similarity 49, member B |
| chr14_-_51297197 | 1.73 |
ENST00000382043.4
|
NIN
|
ninein (GSK3B interacting protein) |
| chr13_-_114898016 | 1.73 |
ENST00000542651.1
ENST00000334062.7 |
RASA3
|
RAS p21 protein activator 3 |
| chr18_-_74844713 | 1.73 |
ENST00000397860.3
|
MBP
|
myelin basic protein |
| chr3_-_5229982 | 1.72 |
ENST00000600805.1
|
AC026202.1
|
Uncharacterized protein |
| chr20_-_50179368 | 1.72 |
ENST00000609943.1
ENST00000609507.1 |
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
| chr6_-_91006627 | 1.71 |
ENST00000537989.1
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
| chr6_+_160390102 | 1.71 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
| chr8_+_37553261 | 1.71 |
ENST00000331569.4
|
ZNF703
|
zinc finger protein 703 |
| chr11_-_130184470 | 1.71 |
ENST00000357899.4
ENST00000397753.1 |
ZBTB44
|
zinc finger and BTB domain containing 44 |
| chr17_-_78194716 | 1.71 |
ENST00000576707.1
|
SGSH
|
N-sulfoglucosamine sulfohydrolase |
| chr3_+_45635661 | 1.71 |
ENST00000440097.1
|
LIMD1
|
LIM domains containing 1 |
| chr1_+_27022839 | 1.70 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
| chr1_+_1447517 | 1.70 |
ENST00000378756.3
ENST00000378755.5 |
ATAD3A
|
ATPase family, AAA domain containing 3A |
| chr10_+_11060004 | 1.70 |
ENST00000542579.1
ENST00000399850.3 ENST00000417956.2 |
CELF2
|
CUGBP, Elav-like family member 2 |
| chr1_-_42800614 | 1.69 |
ENST00000372572.1
|
FOXJ3
|
forkhead box J3 |
| chr20_+_34894247 | 1.69 |
ENST00000373913.3
|
DLGAP4
|
discs, large (Drosophila) homolog-associated protein 4 |
| chr2_-_225907150 | 1.69 |
ENST00000258390.7
|
DOCK10
|
dedicator of cytokinesis 10 |
| chr3_+_16926441 | 1.69 |
ENST00000418129.2
ENST00000396755.2 |
PLCL2
|
phospholipase C-like 2 |
| chr8_-_28243590 | 1.69 |
ENST00000523095.1
ENST00000522795.1 |
ZNF395
|
zinc finger protein 395 |
| chr5_-_14871866 | 1.69 |
ENST00000284268.6
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator |
| chr6_-_146056341 | 1.69 |
ENST00000435470.1
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) |
| chr20_+_13202418 | 1.68 |
ENST00000262487.4
|
ISM1
|
isthmin 1, angiogenesis inhibitor |
| chr10_-_126432821 | 1.67 |
ENST00000280780.6
|
FAM53B
|
family with sequence similarity 53, member B |
| chr13_+_28712614 | 1.67 |
ENST00000380958.3
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
| chr1_+_206858232 | 1.66 |
ENST00000294981.4
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
| chr14_+_95982451 | 1.66 |
ENST00000554161.1
|
RP11-1070N10.3
|
Uncharacterized protein |
| chr11_+_64073022 | 1.65 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
| chr14_+_90864504 | 1.65 |
ENST00000544280.2
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta) |
| chr3_+_98451532 | 1.65 |
ENST00000486334.2
ENST00000394162.1 |
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
| chr5_+_179233376 | 1.65 |
ENST00000376929.3
ENST00000514093.1 |
SQSTM1
|
sequestosome 1 |
| chr14_-_65346555 | 1.64 |
ENST00000542895.1
ENST00000556626.1 |
SPTB
|
spectrin, beta, erythrocytic |
| chr11_-_67169265 | 1.64 |
ENST00000358239.4
ENST00000376745.4 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
| chr16_+_68279256 | 1.63 |
ENST00000564827.2
ENST00000566188.1 ENST00000444212.2 ENST00000568082.1 |
PLA2G15
|
phospholipase A2, group XV |
| chr7_-_134855517 | 1.62 |
ENST00000430372.1
|
C7orf49
|
chromosome 7 open reading frame 49 |
| chr1_-_19229014 | 1.62 |
ENST00000538839.1
ENST00000290597.5 |
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1 |
| chr17_+_36861735 | 1.62 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
| chr21_-_16437255 | 1.62 |
ENST00000400199.1
ENST00000400202.1 |
NRIP1
|
nuclear receptor interacting protein 1 |
| chr10_+_99079008 | 1.62 |
ENST00000371021.3
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas |
| chr16_+_89160269 | 1.61 |
ENST00000540697.1
ENST00000406948.3 ENST00000378345.4 ENST00000541755.2 |
ACSF3
|
acyl-CoA synthetase family member 3 |
| chr1_-_226070016 | 1.61 |
ENST00000366835.3
|
TMEM63A
|
transmembrane protein 63A |
| chr6_-_24911195 | 1.61 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
| chr16_-_11680759 | 1.60 |
ENST00000571459.1
ENST00000570798.1 ENST00000572255.1 ENST00000574763.1 ENST00000574703.1 ENST00000571277.1 ENST00000381810.3 |
LITAF
|
lipopolysaccharide-induced TNF factor |
| chrX_-_153714917 | 1.60 |
ENST00000369653.4
|
UBL4A
|
ubiquitin-like 4A |
| chr17_-_66287257 | 1.60 |
ENST00000327268.4
|
SLC16A6
|
solute carrier family 16, member 6 |
| chr10_-_6622258 | 1.59 |
ENST00000263125.5
|
PRKCQ
|
protein kinase C, theta |
| chr17_-_4890919 | 1.59 |
ENST00000572543.1
ENST00000381311.5 ENST00000348066.3 ENST00000358183.4 |
CAMTA2
|
calmodulin binding transcription activator 2 |
| chr9_-_139581875 | 1.59 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr1_+_150522222 | 1.59 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chrX_+_154611749 | 1.59 |
ENST00000369505.3
|
F8A2
|
coagulation factor VIII-associated 2 |
| chr5_-_133340326 | 1.59 |
ENST00000425992.1
ENST00000395044.3 ENST00000395047.2 |
VDAC1
|
voltage-dependent anion channel 1 |
| chr4_+_1003742 | 1.59 |
ENST00000398484.2
|
FGFRL1
|
fibroblast growth factor receptor-like 1 |
| chr9_-_138987115 | 1.58 |
ENST00000277554.2
|
NACC2
|
NACC family member 2, BEN and BTB (POZ) domain containing |
| chr7_-_149470540 | 1.58 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
| chr12_-_122907091 | 1.58 |
ENST00000358808.2
ENST00000361654.4 ENST00000539080.1 ENST00000537178.1 |
CLIP1
|
CAP-GLY domain containing linker protein 1 |
| chr2_+_131113609 | 1.57 |
ENST00000347849.3
|
PTPN18
|
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
| chr4_+_2819883 | 1.57 |
ENST00000511747.1
ENST00000503393.2 |
SH3BP2
|
SH3-domain binding protein 2 |
| chr16_+_66638685 | 1.57 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr13_-_53024725 | 1.57 |
ENST00000378060.4
|
VPS36
|
vacuolar protein sorting 36 homolog (S. cerevisiae) |
| chr19_+_58919992 | 1.57 |
ENST00000306910.4
ENST00000598901.1 ENST00000593920.1 ENST00000596281.1 |
ZNF584
|
zinc finger protein 584 |
| chr16_-_85045069 | 1.56 |
ENST00000564466.1
|
ZDHHC7
|
zinc finger, DHHC-type containing 7 |
| chr8_-_33424636 | 1.56 |
ENST00000256257.1
|
RNF122
|
ring finger protein 122 |
| chr5_-_133340682 | 1.56 |
ENST00000265333.3
|
VDAC1
|
voltage-dependent anion channel 1 |
| chr12_-_76477707 | 1.56 |
ENST00000551992.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr19_-_58919815 | 1.56 |
ENST00000597980.1
|
CTD-2619J13.14
|
CTD-2619J13.14 |
| chr19_-_3061397 | 1.56 |
ENST00000586839.1
|
AES
|
amino-terminal enhancer of split |
| chr7_-_100487280 | 1.55 |
ENST00000388761.2
|
UFSP1
|
UFM1-specific peptidase 1 (non-functional) |
| chr18_+_11981014 | 1.55 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr6_-_134495992 | 1.55 |
ENST00000475719.2
ENST00000367857.5 ENST00000237305.7 |
SGK1
|
serum/glucocorticoid regulated kinase 1 |
| chr8_+_38758737 | 1.54 |
ENST00000521746.1
ENST00000420274.1 |
PLEKHA2
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 |
| chr7_+_150065879 | 1.54 |
ENST00000397281.2
ENST00000444957.1 ENST00000466559.1 ENST00000489432.2 ENST00000475514.1 ENST00000482680.1 ENST00000488943.1 ENST00000518514.1 ENST00000478789.1 |
REPIN1
ZNF775
|
replication initiator 1 zinc finger protein 775 |
| chr16_+_68279207 | 1.54 |
ENST00000413021.2
ENST00000565744.1 ENST00000219345.5 |
PLA2G15
|
phospholipase A2, group XV |
| chr11_+_45825896 | 1.54 |
ENST00000314134.3
|
SLC35C1
|
solute carrier family 35 (GDP-fucose transporter), member C1 |
| chr1_+_207226574 | 1.53 |
ENST00000367080.3
ENST00000367079.2 |
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
| chr6_-_4135693 | 1.53 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr17_-_1532106 | 1.53 |
ENST00000301335.5
ENST00000382147.4 |
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2 |
| chr1_-_156721389 | 1.53 |
ENST00000537739.1
|
HDGF
|
hepatoma-derived growth factor |
Network of associatons between targets according to the STRING database.
First level regulatory network of MECP2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 8.2 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 1.7 | 5.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 1.3 | 3.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 1.2 | 3.7 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 1.2 | 6.1 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.2 | 3.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 1.2 | 4.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 1.1 | 3.4 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 1.1 | 4.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.0 | 3.9 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 1.0 | 3.8 | GO:1905045 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 1.0 | 3.8 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.9 | 2.8 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.9 | 2.7 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.9 | 4.5 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.9 | 3.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.9 | 2.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.9 | 3.5 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.8 | 2.5 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.8 | 1.7 | GO:0016049 | cell growth(GO:0016049) |
| 0.8 | 3.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.8 | 2.5 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.8 | 3.3 | GO:0032848 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.8 | 5.6 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.8 | 0.8 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.8 | 2.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.8 | 3.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.8 | 7.0 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.8 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.8 | 2.3 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.8 | 3.8 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.8 | 4.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.8 | 2.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.7 | 3.0 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.7 | 3.0 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.7 | 1.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.7 | 5.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.7 | 3.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.7 | 4.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.7 | 0.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.7 | 0.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 | 5.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.7 | 2.8 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.7 | 5.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.7 | 3.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.7 | 2.8 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.7 | 2.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.7 | 2.7 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.7 | 4.6 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 0.7 | 2.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.6 | 1.9 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.6 | 2.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.6 | 1.9 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.6 | 1.9 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.6 | 1.9 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.6 | 0.6 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.6 | 1.9 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.6 | 1.9 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.6 | 0.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.6 | 5.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.6 | 0.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.6 | 3.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.6 | 4.2 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.6 | 1.8 | GO:0071338 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.6 | 2.3 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.6 | 1.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.6 | 2.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.6 | 0.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.6 | 1.7 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.6 | 1.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.6 | 2.9 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.6 | 4.0 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
| 0.6 | 3.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.6 | 3.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.6 | 4.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.6 | 1.7 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.6 | 5.5 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.5 | 8.1 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.5 | 2.7 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.5 | 2.2 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 0.5 | 2.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 | 2.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.5 | 8.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.5 | 5.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.5 | 8.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.5 | 1.6 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.5 | 1.6 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.5 | 4.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.5 | 2.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.5 | 3.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.5 | 2.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.5 | 3.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.5 | 2.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.5 | 0.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.5 | 3.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 | 3.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.5 | 2.0 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.5 | 2.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.5 | 1.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.5 | 4.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.5 | 2.0 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.5 | 0.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.5 | 1.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.5 | 1.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 | 1.0 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
| 0.5 | 1.0 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.5 | 1.5 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.5 | 1.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.5 | 0.5 | GO:2001076 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.5 | 7.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.5 | 1.9 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.5 | 1.0 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.5 | 2.4 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.5 | 4.3 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.5 | 2.4 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.5 | 1.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.5 | 2.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.5 | 5.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.5 | 1.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.5 | 1.4 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.5 | 1.4 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.5 | 1.4 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.5 | 2.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.5 | 2.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.5 | 2.3 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.5 | 0.9 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.5 | 3.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.5 | 1.8 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.5 | 1.8 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.5 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 | 2.3 | GO:0032796 | uropod organization(GO:0032796) |
| 0.5 | 1.8 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.5 | 2.3 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.5 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.5 | 2.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.5 | 1.4 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.5 | 1.4 | GO:0060691 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
| 0.5 | 1.8 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.4 | 2.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.4 | 0.4 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.4 | 1.3 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.4 | 3.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.4 | 5.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.4 | 4.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.4 | 2.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.4 | 4.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.4 | 2.2 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.4 | 2.6 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.4 | 0.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 | 1.3 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.4 | 2.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.4 | 0.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.4 | 0.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.4 | 1.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.4 | 1.3 | GO:0014040 | acetaldehyde metabolic process(GO:0006117) positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.4 | 1.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.4 | 6.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.4 | 1.3 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 0.4 | 1.2 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.4 | 1.2 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.4 | 2.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 | 1.2 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.4 | 1.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.4 | 2.9 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
| 0.4 | 3.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 | 0.8 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.4 | 2.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.4 | 2.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 | 0.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.4 | 1.6 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.4 | 1.2 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.4 | 0.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.4 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
| 0.4 | 1.2 | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
| 0.4 | 0.4 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.4 | 0.4 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.4 | 0.8 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.4 | 1.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.4 | 3.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.4 | 0.8 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.4 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.4 | 1.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.4 | 1.6 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.4 | 3.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.4 | 6.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.4 | 1.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 | 0.4 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.4 | 2.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.4 | 3.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 | 0.8 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.4 | 2.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.4 | 1.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.4 | 2.7 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.4 | 0.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.4 | 0.4 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.4 | 1.2 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.4 | 0.8 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.4 | 1.2 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.4 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.4 | 1.5 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.4 | 1.5 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.4 | 2.3 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.4 | 1.9 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.4 | 1.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.4 | 1.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 | 1.1 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 | 1.1 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.4 | 1.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.4 | 1.9 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.4 | 3.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 | 1.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.4 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.4 | 1.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.4 | 4.9 | GO:0060022 | hard palate development(GO:0060022) |
| 0.4 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 0.7 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 14.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.4 | 1.1 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
| 0.4 | 1.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.4 | 1.8 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.4 | 1.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.4 | 3.3 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.4 | 1.1 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.4 | 0.7 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.4 | 0.7 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.4 | 6.6 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.4 | 1.1 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.4 | 4.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 | 1.5 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.4 | 1.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.4 | 1.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.4 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.4 | 1.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.4 | 1.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.4 | 3.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.4 | 0.4 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
| 0.4 | 5.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 | 2.1 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 | 2.5 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.4 | 1.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.4 | 3.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.4 | 0.4 | GO:1904951 | positive regulation of establishment of protein localization(GO:1904951) |
| 0.4 | 1.1 | GO:0032618 | interleukin-15 production(GO:0032618) |
| 0.4 | 0.7 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 | 0.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.3 | 2.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.3 | 7.0 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.3 | 0.7 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.3 | 1.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.3 | 1.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 0.7 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.3 | 1.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.3 | 1.0 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.3 | 1.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.3 | 4.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 5.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 | 1.4 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.3 | 4.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.3 | 2.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 2.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 1.4 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.3 | 0.7 | GO:0070781 | response to biotin(GO:0070781) |
| 0.3 | 0.3 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.3 | 6.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 | 2.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.3 | 0.3 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.3 | 3.0 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.3 | 1.3 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.3 | 0.3 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.3 | 2.0 | GO:2001153 | negative regulation of glycogen (starch) synthase activity(GO:2000466) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.3 | 0.7 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.3 | 0.3 | GO:0035148 | tube formation(GO:0035148) |
| 0.3 | 0.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.3 | 1.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.3 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.3 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.3 | 4.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.3 | 0.6 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.3 | 1.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.3 | 1.0 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.3 | 1.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.3 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 | 0.3 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.3 | 2.6 | GO:0046618 | drug export(GO:0046618) |
| 0.3 | 1.6 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.3 | 1.0 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.3 | 5.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.3 | 5.7 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.3 | 0.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.3 | 3.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.3 | 1.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.3 | 1.3 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
| 0.3 | 1.3 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.3 | 0.9 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.3 | 6.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 0.9 | GO:1904640 | response to methionine(GO:1904640) |
| 0.3 | 1.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.3 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.3 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.3 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.3 | 0.6 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.3 | 2.5 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.3 | 1.2 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.3 | 1.2 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.3 | 1.5 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
| 0.3 | 0.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 | 0.9 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.3 | 2.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 | 2.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 | 0.9 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.3 | 0.9 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) cell proliferation involved in heart valve development(GO:2000793) |
| 0.3 | 5.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.3 | 3.9 | GO:0030091 | protein repair(GO:0030091) |
| 0.3 | 0.3 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.3 | 2.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 3.9 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.3 | 1.8 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 0.3 | 1.8 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 0.3 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 | 1.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 | 1.5 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.3 | 1.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.3 | 0.9 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.3 | 0.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.3 | 2.4 | GO:0045007 | depurination(GO:0045007) |
| 0.3 | 3.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 1.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.3 | 0.3 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.3 | 2.6 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.3 | 0.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.3 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 | 1.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 | 2.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.3 | 2.0 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.3 | 2.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.3 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.3 | 1.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 0.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 | 2.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.3 | 0.6 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.3 | 1.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.3 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 | 2.0 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.3 | 1.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.3 | 0.6 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
| 0.3 | 1.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.3 | 8.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.3 | 0.3 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.3 | 1.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.3 | 1.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.3 | 1.4 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.3 | 0.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.3 | 3.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.3 | 0.8 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.3 | 7.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.3 | 4.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 | 4.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.3 | 0.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 | 1.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.3 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.3 | 0.8 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.3 | 1.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.3 | 39.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.3 | 1.1 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.3 | 0.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.3 | 1.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 | 1.3 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.3 | 0.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.3 | 0.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.3 | 1.1 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) |
| 0.3 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.3 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.3 | 1.6 | GO:0043366 | beta selection(GO:0043366) |
| 0.3 | 5.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.3 | 2.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.3 | 1.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 1.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 | 4.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.3 | 0.8 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.3 | 2.1 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.3 | 0.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.3 | 0.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.3 | 0.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.3 | 0.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.3 | 3.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.3 | 1.0 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.3 | 1.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.3 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 | 2.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.3 | 5.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.3 | 0.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.3 | 4.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.3 | 3.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 | 3.9 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.3 | 0.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.3 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.3 | 0.8 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.3 | 1.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.3 | 5.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.3 | 2.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 1.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.3 | 0.8 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.3 | 0.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.3 | 3.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.3 | 0.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.3 | 0.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 | 2.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 | 1.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 | 1.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.2 | 2.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.2 | 3.0 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.2 | 0.7 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 | 1.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.2 | 2.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.2 | 1.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 2.9 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 2.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.2 | 0.5 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
| 0.2 | 3.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 0.7 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.2 | 1.7 | GO:0071964 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.2 | 0.5 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.2 | 1.7 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.2 | 0.5 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.2 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.2 | 1.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
| 0.2 | 0.5 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 0.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 | 1.4 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 0.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.2 | 2.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.2 | 3.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.2 | 1.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 3.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.2 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 | 1.7 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.2 | 1.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 | 1.2 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.2 | 1.2 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
| 0.2 | 0.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 | 1.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.2 | 1.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 2.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 1.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.2 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
| 0.2 | 0.9 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.2 | 0.2 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.2 | 1.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.2 | 0.5 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.2 | 4.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 1.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 | 0.7 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.2 | 0.2 | GO:0060038 | cardiac muscle cell proliferation(GO:0060038) heart growth(GO:0060419) |
| 0.2 | 0.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.2 | 2.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 0.7 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
| 0.2 | 2.8 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
| 0.2 | 1.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.2 | 1.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.2 | 1.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 | 3.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.2 | 1.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.2 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.2 | 7.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.2 | 1.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.2 | 0.5 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.2 | 3.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.2 | 0.5 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.2 | 0.7 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 4.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.2 | 1.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.2 | 5.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 0.7 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.2 | 0.5 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 | 1.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.2 | 5.2 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.2 | 6.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.2 | 0.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.2 | 0.5 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.2 | 1.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.2 | 0.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.2 | 2.9 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.2 | 2.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 3.6 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.2 | 5.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.2 | 0.7 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 | 6.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 | 2.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.2 | 0.9 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.2 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.2 | 5.3 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
| 0.2 | 2.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.2 | 2.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 0.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.2 | 1.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 1.3 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 1.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 2.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 | 2.0 | GO:1901563 | response to camptothecin(GO:1901563) |
| 0.2 | 2.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 0.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.2 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.2 | 0.7 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.2 | 0.7 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.2 | 0.9 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.2 | 0.4 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.2 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.2 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 | 1.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 | 1.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.2 | 0.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.2 | 1.3 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) |
| 0.2 | 5.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.2 | 8.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
| 0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 0.2 | 2.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 | 2.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.2 | 0.2 | GO:2000197 | regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.2 | 0.9 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 | 0.6 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.2 | 0.9 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 | 3.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 | 0.9 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.2 | 2.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 1.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.2 | 3.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 | 0.9 | GO:0000019 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
| 0.2 | 0.2 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
| 0.2 | 2.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.2 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 3.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.2 | 1.1 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.2 | 1.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.2 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 0.2 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.2 | 1.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.2 | 0.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 | 0.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.2 | 1.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.2 | 1.7 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.2 | 1.0 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.2 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 | 1.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 3.7 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 1.0 | GO:0001757 | somite specification(GO:0001757) |
| 0.2 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.2 | 2.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.2 | 2.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 0.6 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.2 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.2 | 3.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
| 0.2 | 3.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 0.4 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.2 | 1.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 0.4 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.2 | 0.6 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.2 | 0.6 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
| 0.2 | 0.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.2 | 0.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.2 | 1.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 1.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 0.6 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.2 | 1.8 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.2 | 0.2 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
| 0.2 | 2.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.2 | 2.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 | 0.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 0.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 3.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 | 0.4 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
| 0.2 | 1.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.2 | 1.0 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 | 1.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.2 | 0.8 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.2 | 0.6 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.2 | 0.8 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.2 | 0.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.2 | 0.6 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.2 | 1.0 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.2 | 0.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.2 | 0.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 | 1.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
| 0.2 | 2.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 2.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 4.7 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.2 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 0.2 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 0.2 | 2.5 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.2 | 0.8 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.2 | 0.6 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.2 | 1.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.2 | 0.4 | GO:0019076 | viral release from host cell(GO:0019076) |
| 0.2 | 0.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.2 | 3.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.2 | 0.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.2 | 4.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.2 | 0.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 | 0.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 | 0.6 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.2 | 0.8 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.2 | 2.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 1.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 1.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 | 0.6 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.2 | 1.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 0.2 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.2 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 14.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.2 | 0.6 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.2 | 1.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 1.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 0.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.2 | 1.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.2 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.2 | 0.8 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.2 | 0.2 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
| 0.2 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.2 | 21.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.2 | 0.9 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.2 | 2.2 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
| 0.2 | 7.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 0.6 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.2 | 3.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 1.1 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 | 0.7 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.2 | 0.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.2 | 1.1 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.2 | 2.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.2 | 1.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 | 4.9 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 | 0.9 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.2 | 1.8 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.2 | 0.7 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.2 | 2.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 | 2.0 | GO:0060613 | fat pad development(GO:0060613) |
| 0.2 | 0.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.2 | 1.3 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.2 | 1.1 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.2 | 1.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 | 0.5 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.2 | 1.1 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 | 0.5 | GO:0030048 | actin filament-based movement(GO:0030048) |
| 0.2 | 0.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 1.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.2 | 1.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.2 | 0.4 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.2 | 0.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.2 | 5.9 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.2 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.2 | 3.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 | 2.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 | 0.5 | GO:0097680 | DNA ligation involved in DNA recombination(GO:0051102) double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.2 | 0.4 | GO:0040012 | regulation of locomotion(GO:0040012) |
| 0.2 | 0.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.2 | 0.2 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.2 | 1.1 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
| 0.2 | 2.3 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.2 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.2 | 0.2 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.2 | 0.7 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 0.2 | 3.9 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 | 0.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.2 | 4.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.2 | 6.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 | 1.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 3.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.2 | 0.9 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.2 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 3.3 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.2 | 1.4 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.2 | 1.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.2 | 0.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.2 | 1.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 | 0.5 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.2 | 0.9 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.2 | 1.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 1.5 | GO:0031054 | pre-miRNA processing(GO:0031054) |
| 0.2 | 3.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 | 1.7 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.2 | 2.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.2 | 3.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.2 | 0.3 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.2 | 3.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.2 | 0.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.2 | 0.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 | 4.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 2.0 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.2 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.2 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.2 | 0.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 | 1.5 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 2.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.2 | 1.3 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.2 | 3.3 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
| 0.2 | 0.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.2 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 2.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.2 | 1.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 | 0.2 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.2 | 0.2 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
| 0.2 | 0.3 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.2 | 2.0 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.2 | 0.7 | GO:0006116 | NADH oxidation(GO:0006116) glycerophosphate shuttle(GO:0006127) |
| 0.2 | 1.7 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
| 0.2 | 1.6 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
| 0.2 | 0.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.2 | 0.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.2 | 2.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.2 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 0.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.2 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 1.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 | 0.7 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 1.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.2 | 0.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.2 | 8.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.2 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.2 | 0.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 | 0.2 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.2 | 2.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.2 | 1.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.2 | 0.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.2 | 0.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 | 1.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.2 | 2.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 | 11.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 0.8 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.2 | 1.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 | 1.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.2 | 5.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.2 | 5.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.2 | 0.5 | GO:0038111 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.2 | 0.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.2 | 1.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 | 1.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.2 | 0.6 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 | 0.5 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 0.2 | 0.5 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.2 | 3.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.2 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 | 2.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.2 | 2.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.2 | 0.6 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.2 | 0.6 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 0.5 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 0.2 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.2 | 0.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.2 | 0.9 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.2 | 2.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.2 | 1.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.2 | 1.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.2 | 0.6 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 | 0.5 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 | 3.7 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.2 | 1.8 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 | 0.3 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.2 | 1.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 | 1.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.2 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 | 14.4 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.2 | 0.3 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.2 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 | 0.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.2 | 1.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 0.6 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.2 | 0.6 | GO:0003292 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.2 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 | 0.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 1.8 | GO:0015824 | proline transport(GO:0015824) |
| 0.2 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 0.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 1.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.2 | 1.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 0.2 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.1 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 0.6 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) positive regulation of opsonization(GO:1903028) |
| 0.1 | 1.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 | 1.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 6.2 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 1.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 | 0.4 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 | 2.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 0.6 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.1 | 1.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.1 | 0.3 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
| 0.1 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 0.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 1.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 | 1.9 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 | 1.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 | 3.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 | 0.3 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 | 6.4 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
| 0.1 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 | 0.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 2.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 | 2.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.4 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.1 | 3.9 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.1 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.7 | GO:0006000 | fructose metabolic process(GO:0006000) |
| 0.1 | 0.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 | 0.3 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.1 | 1.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.1 | 7.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 0.3 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
| 0.1 | 0.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.1 | 1.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 2.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.7 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.1 | 0.6 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 | 5.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 1.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 8.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 3.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 1.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 | 0.1 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 1.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 1.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.1 | 1.4 | GO:0051095 | regulation of helicase activity(GO:0051095) |
| 0.1 | 1.5 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 0.8 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.1 | 0.3 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.1 | 1.1 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 1.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 0.7 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 1.4 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
| 0.1 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.1 | 1.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 1.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 1.9 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.1 | 1.6 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 | 1.0 | GO:0015677 | copper ion import(GO:0015677) |
| 0.1 | 3.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 0.4 | GO:0010949 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.1 | 0.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.1 | 0.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.1 | 1.2 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.1 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 1.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 2.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 2.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 1.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 0.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 | 0.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 2.4 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 0.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.3 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 | 2.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 1.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.1 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 1.9 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 0.1 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.1 | 1.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.1 | 1.6 | GO:0009629 | response to gravity(GO:0009629) |
| 0.1 | 0.5 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.4 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.1 | 73.8 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.1 | 1.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 3.8 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 | 1.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.4 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 | 1.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.1 | 1.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 0.6 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 1.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 0.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.1 | 0.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 | 1.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 | 0.4 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
| 0.1 | 0.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 0.1 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) RNA repair(GO:0042245) |
| 0.1 | 0.9 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.1 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 0.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.1 | 1.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.3 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.1 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 1.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 1.7 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 1.3 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.1 | 1.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 1.4 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 | 0.3 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 4.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 0.3 | GO:0044532 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
| 0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 0.6 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.1 | 1.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 1.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 | 0.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 0.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.1 | 0.2 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 | 5.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 0.2 | GO:0006678 | acetate metabolic process(GO:0006083) glucosylceramide metabolic process(GO:0006678) |
| 0.1 | 3.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 1.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.1 | 1.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.1 | 0.2 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.1 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 | 0.7 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.1 | 1.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 0.1 | GO:1901205 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) positive regulation of adrenergic receptor signaling pathway(GO:0071879) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.1 | 1.2 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
| 0.1 | 2.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 1.6 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
| 0.1 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 | 1.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 1.0 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 0.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.1 | 1.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.7 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 | 0.2 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.1 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.1 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 3.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 2.2 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.1 | 0.4 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 | 1.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 | 7.9 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.1 | 0.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 | 0.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.1 | GO:1903094 | negative regulation of protein deubiquitination(GO:0090086) regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 | 1.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.1 | 0.9 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 0.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 0.7 | GO:1902460 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 | 0.8 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 0.3 | GO:0046203 | spermidine catabolic process(GO:0046203) |
| 0.1 | 0.6 | GO:0018158 | protein oxidation(GO:0018158) |
| 0.1 | 0.9 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 0.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.8 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 | 1.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.1 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.1 | 1.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.1 | 0.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.4 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.1 | 0.3 | GO:0070839 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.1 | 1.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 0.8 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 1.2 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 1.6 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 0.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 1.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 2.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.9 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 5.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.1 | 0.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 1.1 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 8.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
| 0.1 | 1.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.1 | 2.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 1.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 1.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 | 0.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.2 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.1 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 1.2 | GO:0070265 | necrotic cell death(GO:0070265) |
| 0.1 | 0.4 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.1 | 0.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.1 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 3.4 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.1 | 0.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 0.1 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 2.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 | 0.6 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 1.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 1.9 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.1 | 4.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 0.5 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
| 0.1 | 4.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 6.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.1 | 1.5 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.2 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 | 0.3 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.1 | 0.2 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.1 | 0.2 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 0.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.1 | 16.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.1 | 1.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.1 | 1.0 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
| 0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.4 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 1.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.1 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.1 | 1.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 | 1.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 | 1.8 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 4.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 | 0.5 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.8 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.7 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 1.4 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
| 0.1 | 1.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 6.1 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
| 0.1 | 0.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 0.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 0.4 | GO:0006956 | complement activation(GO:0006956) |
| 0.1 | 0.2 | GO:0051604 | protein maturation(GO:0051604) |
| 0.1 | 0.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 2.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 2.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 2.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.1 | 0.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.1 | 5.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 1.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 | 0.6 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.1 | 0.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 1.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 1.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 2.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 7.9 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 | 1.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.1 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.1 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 3.4 | GO:0046782 | regulation of viral transcription(GO:0046782) |
| 0.1 | 9.3 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 1.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 0.7 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 | 0.6 | GO:0019075 | virus maturation(GO:0019075) |
| 0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 | 0.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 1.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 1.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 | 1.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 4.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 1.0 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 | 0.5 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.1 | 3.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 3.1 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 0.3 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.1 | 1.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 10.0 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 2.6 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 0.4 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.1 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.1 | 0.6 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 3.2 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.1 | 1.9 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 1.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 1.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.1 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 0.6 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.1 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.1 | 0.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 3.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 0.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 0.2 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.1 | 0.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 | 0.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 | 2.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.1 | 0.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 1.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 0.1 | 1.0 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.1 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.4 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 | 0.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.1 | 10.6 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.1 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.1 | 0.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 3.1 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.1 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 2.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 0.4 | GO:0006771 | riboflavin metabolic process(GO:0006771) |
| 0.1 | 2.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.1 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.4 | GO:1904744 | regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 | 0.6 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.3 | GO:0070893 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.1 | 1.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.4 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
| 0.1 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 1.5 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 | 0.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 | 1.8 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.1 | 0.8 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.1 | 3.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.5 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
| 0.1 | 0.4 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
| 0.1 | 0.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
| 0.1 | 0.1 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.1 | 4.2 | GO:1900076 | regulation of cellular response to insulin stimulus(GO:1900076) |
| 0.1 | 0.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 4.3 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.1 | 0.4 | GO:0006685 | sphingomyelin metabolic process(GO:0006684) sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.1 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.1 | 1.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 0.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.1 | 0.3 | GO:0015866 | ADP transport(GO:0015866) |
| 0.1 | 0.3 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.1 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 1.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.1 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 1.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) |
| 0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.1 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.1 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.1 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 1.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 0.9 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 1.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 4.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 | 0.7 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
| 0.1 | 0.3 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.1 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.1 | 0.5 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) |
| 0.1 | 3.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 | 1.0 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 0.5 | GO:0046463 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 | 0.2 | GO:0035572 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 1.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 0.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 0.3 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
| 0.1 | 1.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 5.0 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.1 | 2.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.6 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.1 | 0.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.4 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 0.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.1 | 1.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.1 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 | 0.2 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.1 | 0.3 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 0.6 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 1.2 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
| 0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 1.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.6 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 | 0.2 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
| 0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 0.4 | GO:0070293 | renal absorption(GO:0070293) |
| 0.1 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 | 0.4 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.1 | 0.1 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.1 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 1.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.1 | 2.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 | 0.2 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) modulation of growth of symbiont involved in interaction with host(GO:0044144) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.1 | 0.8 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.1 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
| 0.1 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
| 0.1 | 0.1 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 | 1.0 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
| 0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 1.6 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.1 | 2.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 | 1.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.1 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 8.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 0.1 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
| 0.1 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.1 | 0.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.2 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.1 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 0.3 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 | 0.7 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 1.2 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 0.6 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 | 0.3 | GO:0071389 | cellular response to corticosterone stimulus(GO:0071386) cellular response to mineralocorticoid stimulus(GO:0071389) |
| 0.1 | 0.2 | GO:0070486 | leukocyte aggregation(GO:0070486) |
| 0.1 | 0.1 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.0 | 0.1 | GO:0008016 | regulation of heart contraction(GO:0008016) |
| 0.0 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.0 | 0.2 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 1.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 0.3 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.0 | 0.1 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
| 0.0 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
| 0.0 | 1.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.0 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 | 0.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.0 | 0.1 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 1.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.2 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.0 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 | 0.3 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) response to host(GO:0075136) |
| 0.0 | 0.0 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.0 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 0.4 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
| 0.0 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 | 0.4 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.0 | 0.2 | GO:0071428 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.0 | 0.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular response to salt stress(GO:0071472) cellular hypotonic salinity response(GO:0071477) |
| 0.0 | 0.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.9 | GO:0007567 | parturition(GO:0007567) |
| 0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 | 4.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.0 | 0.0 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.0 | 2.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
| 0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.0 | 0.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
| 0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.0 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.0 | 2.0 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 | 0.2 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.0 | 0.2 | GO:0051665 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
| 0.0 | 0.4 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
| 0.0 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
| 0.0 | 0.1 | GO:0006863 | purine nucleobase transport(GO:0006863) |
| 0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.0 | 2.6 | GO:0010324 | membrane invagination(GO:0010324) |
| 0.0 | 5.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.0 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.0 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 | 0.2 | GO:0098754 | detoxification(GO:0098754) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
| 0.0 | 0.1 | GO:0015822 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 | 0.1 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 | 0.7 | GO:0006397 | mRNA processing(GO:0006397) |
| 0.0 | 0.3 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.0 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.0 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.0 | 0.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.0 | 3.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
| 0.0 | 0.3 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 | 0.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.0 | 0.2 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.0 | 0.7 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 | 1.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.0 | 0.2 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.0 | 0.2 | GO:0060968 | regulation of gene silencing(GO:0060968) |
| 0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 | 0.3 | GO:0048145 | regulation of fibroblast proliferation(GO:0048145) |
| 0.0 | 0.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.0 | 0.2 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.1 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
| 0.0 | 0.6 | GO:0019915 | lipid storage(GO:0019915) |
| 0.0 | 0.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 | 0.2 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
| 0.0 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 | 0.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 1.9 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 0.4 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.5 | GO:0050821 | protein stabilization(GO:0050821) |
| 0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.7 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.1 | GO:1902679 | negative regulation of RNA biosynthetic process(GO:1902679) |
| 0.0 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.0 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.0 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.2 | GO:0061383 | trabecula morphogenesis(GO:0061383) |
| 0.0 | 0.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 | 0.3 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.0 | 0.2 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.0 | GO:0032787 | monocarboxylic acid metabolic process(GO:0032787) |
| 0.0 | 0.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 | 0.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 1.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.8 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 | 0.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 | 0.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 | 0.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.1 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 0.0 | 0.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
| 0.0 | 0.1 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.0 | 0.0 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 | 0.0 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
| 0.0 | 0.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 0.6 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.0 | 0.2 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.0 | 0.2 | GO:0046456 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
| 0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 | 0.2 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
| 0.0 | 0.8 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
| 0.0 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.1 | GO:0061025 | membrane fusion(GO:0061025) |
| 0.0 | 0.7 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
| 0.0 | 0.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.0 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 0.1 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.0 | 0.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
| 0.0 | 0.0 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
| 0.0 | 0.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.0 | 0.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.0 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.0 | 0.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.0 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.0 | 0.1 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.0 | 0.4 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.0 | 0.0 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.0 | 0.0 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
| 0.0 | 0.4 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.0 | 0.1 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.0 | 0.0 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.0 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
| 0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
| 0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.0 | 0.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.0 | 1.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 1.3 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
| 0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 | 0.1 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.0 | 0.0 | GO:1903826 | arginine transport(GO:0015809) arginine transmembrane transport(GO:1903826) |
| 0.0 | 0.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.0 | 0.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.0 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 0.2 | GO:0031103 | axon regeneration(GO:0031103) |
| 0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.0 | 0.0 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.0 | 0.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.1 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.0 | 0.0 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.0 | 0.2 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 2.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.9 | 3.7 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.9 | 2.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.8 | 3.3 | GO:0044753 | amphisome(GO:0044753) |
| 0.8 | 3.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.7 | 2.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.6 | 1.8 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 0.6 | 1.8 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.6 | 2.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.5 | 2.2 | GO:0043204 | perikaryon(GO:0043204) |
| 0.5 | 2.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.5 | 12.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.5 | 1.6 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.5 | 7.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.5 | 1.5 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.5 | 3.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.5 | 1.5 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.5 | 2.0 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.5 | 1.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.5 | 5.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.5 | 8.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.5 | 2.4 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.5 | 2.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.5 | 1.8 | GO:0019867 | outer membrane(GO:0019867) |
| 0.4 | 1.8 | GO:0043293 | apoptosome(GO:0043293) |
| 0.4 | 2.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.4 | 1.7 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.4 | 6.0 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.4 | 1.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.4 | 1.3 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.4 | 3.4 | GO:0001740 | Barr body(GO:0001740) |
| 0.4 | 3.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.4 | 1.7 | GO:0031251 | PAN complex(GO:0031251) |
| 0.4 | 2.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.4 | 2.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.4 | 0.8 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.4 | 3.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 4.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.4 | 3.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 2.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.4 | 2.1 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.4 | 3.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.4 | 2.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.4 | 2.5 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
| 0.4 | 1.4 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.3 | 2.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.3 | 1.0 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.3 | 1.0 | GO:0030689 | Noc complex(GO:0030689) |
| 0.3 | 1.4 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.3 | 1.7 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.3 | 1.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.3 | 2.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.3 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.3 | 1.0 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.3 | 2.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.3 | 1.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.3 | 2.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 2.3 | GO:0034448 | EGO complex(GO:0034448) |
| 0.3 | 0.6 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.3 | 3.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.3 | 3.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.3 | 1.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.3 | 4.6 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.3 | 8.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.3 | 1.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 1.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.3 | 2.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.3 | 0.9 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.3 | 4.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.3 | 2.3 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.3 | 1.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.3 | 2.3 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 1.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.3 | 1.7 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.3 | 5.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.3 | 0.6 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.3 | 3.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 2.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.3 | 2.2 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.3 | 2.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.3 | 1.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.3 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
| 0.3 | 1.1 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.3 | 1.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 6.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 0.8 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.3 | 1.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.3 | 1.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 1.6 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.3 | 5.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.3 | 31.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.3 | 2.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 4.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.3 | 0.8 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.3 | 4.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.3 | 18.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.3 | 1.8 | GO:0071203 | WASH complex(GO:0071203) |
| 0.3 | 3.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.3 | 7.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.3 | 2.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.3 | 1.8 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.2 | 8.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.2 | 1.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.2 | 4.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.2 | 5.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.2 | 5.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.2 | 8.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.2 | 2.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 2.7 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 6.6 | GO:0046930 | pore complex(GO:0046930) |
| 0.2 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.2 | 1.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.2 | 1.0 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 3.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.2 | 3.6 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 3.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 3.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.2 | 0.9 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.2 | 2.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 1.6 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.2 | 1.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 0.7 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.2 | 0.5 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.2 | 2.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.2 | 1.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 16.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 1.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.2 | 0.7 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.2 | 0.2 | GO:0032059 | bleb(GO:0032059) |
| 0.2 | 1.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.2 | 2.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 9.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.2 | 0.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.2 | 13.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.2 | 3.5 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.2 | 6.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.2 | 6.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.2 | 3.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.2 | 0.2 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.2 | 2.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 5.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.2 | 2.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 2.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 1.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 0.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.2 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.2 | 2.1 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.2 | 0.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.2 | 1.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 1.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 1.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.2 | 0.6 | GO:0000805 | X chromosome(GO:0000805) |
| 0.2 | 2.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.2 | 0.8 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.2 | 13.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.2 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 1.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 5.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 36.0 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 2.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 0.6 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.2 | 20.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 5.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.2 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.2 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.2 | 1.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.2 | 2.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.2 | 1.0 | GO:0000938 | GARP complex(GO:0000938) |
| 0.2 | 1.9 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.2 | 1.9 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 2.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 2.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.2 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.2 | 4.2 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.2 | 6.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.2 | 1.6 | GO:0097413 | Lewy body(GO:0097413) |
| 0.2 | 0.9 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.2 | 0.5 | GO:0008623 | CHRAC(GO:0008623) |
| 0.2 | 0.5 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.2 | 0.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.2 | 1.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.2 | 27.4 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.2 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.2 | 0.7 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.2 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.2 | 0.5 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.2 | 0.5 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.2 | 0.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.2 | 2.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 11.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.2 | 35.0 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.2 | 3.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.2 | 0.5 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.2 | 2.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 6.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.2 | 12.5 | GO:0005776 | autophagosome(GO:0005776) |
| 0.2 | 17.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 1.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 5.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.2 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 1.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 2.0 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 16.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.2 | 2.8 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.2 | 2.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 1.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 1.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.2 | 1.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.2 | 0.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.2 | 6.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.2 | 12.3 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 1.6 | GO:0051286 | cell tip(GO:0051286) |
| 0.2 | 2.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 4.1 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 0.5 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.2 | 1.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.2 | 0.5 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.2 | 3.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.2 | 0.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.2 | 11.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 0.8 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.2 | 0.3 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.2 | 0.3 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
| 0.2 | 2.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 5.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
| 0.1 | 0.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 3.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 3.7 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 1.0 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.1 | 20.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.1 | 1.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 5.5 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 1.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 2.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 3.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 14.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 1.7 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.1 | 0.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.1 | 0.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 1.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.1 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 1.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 0.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.1 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 1.9 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 4.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 2.5 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 2.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 7.0 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 2.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 2.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 1.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 57.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.1 | 1.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 0.4 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.1 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.1 | 0.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 0.5 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 1.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 0.5 | GO:0031592 | centrosomal corona(GO:0031592) |
| 0.1 | 1.3 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 0.1 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 1.3 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.1 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 3.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 2.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 0.9 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 3.1 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 3.6 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 1.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 2.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.1 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 0.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 42.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.1 | 7.0 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 13.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 2.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.3 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.1 | 1.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 8.3 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 7.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.5 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 2.5 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 0.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 0.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 0.5 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.1 | 2.0 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 1.7 | GO:0097708 | intracellular vesicle(GO:0097708) |
| 0.1 | 2.6 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 2.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.1 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 1.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 6.5 | GO:0032994 | protein-lipid complex(GO:0032994) |
| 0.1 | 0.3 | GO:0045121 | membrane raft(GO:0045121) |
| 0.1 | 0.4 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 9.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 7.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 1.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.1 | 1.3 | GO:0030684 | preribosome(GO:0030684) |
| 0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 30.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 0.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.1 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 100.2 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.1 | 16.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 0.7 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.1 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 1.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 1.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.1 | 0.8 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 0.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.1 | 2.3 | GO:0005840 | ribosome(GO:0005840) |
| 0.1 | 5.1 | GO:0016234 | inclusion body(GO:0016234) |
| 0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.1 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 29.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 1.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 0.5 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.1 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 0.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 1.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 24.7 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 6.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 3.6 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 6.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.7 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 3.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
| 0.1 | 3.2 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 3.1 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 1.8 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 2.5 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.6 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.1 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 2.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 2.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.2 | GO:0097361 | CIA complex(GO:0097361) |
| 0.1 | 0.6 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.1 | 1.6 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.5 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 9.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
| 0.1 | 0.5 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 1.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.1 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.1 | 2.0 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
| 0.1 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 5.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 1.1 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
| 0.1 | 5.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 3.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
| 0.0 | 0.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.0 | 4.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.0 | 2.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.2 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.0 | 0.2 | GO:0044304 | main axon(GO:0044304) |
| 0.0 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 1.2 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.4 | GO:0000785 | chromatin(GO:0000785) |
| 0.0 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.0 | 1.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 3.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 0.5 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 1.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 1.3 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 0.4 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 0.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.0 | 0.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 9.9 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.1 | GO:0097196 | Shu complex(GO:0097196) |
| 0.0 | 0.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.0 | 1.2 | GO:0098791 | Golgi subcompartment(GO:0098791) |
| 0.0 | 0.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.0 | 0.2 | GO:0034708 | methyltransferase complex(GO:0034708) |
| 0.0 | 0.4 | GO:0044440 | endosomal part(GO:0044440) |
| 0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 3.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 0.2 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 87.2 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 2.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.0 | 11.3 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 1.8 | GO:0031967 | organelle envelope(GO:0031967) envelope(GO:0031975) |
| 0.0 | 0.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.0 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 1.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 7.2 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 8.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 0.0 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.0 | 0.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 8.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 2.0 | 6.1 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 1.6 | 1.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 1.4 | 4.3 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 1.3 | 3.8 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 1.2 | 4.7 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.1 | 3.4 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 1.0 | 6.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.0 | 3.0 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.9 | 2.8 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.9 | 2.8 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.9 | 4.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.9 | 4.5 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.9 | 3.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.9 | 2.7 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.9 | 2.7 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.9 | 5.3 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.8 | 2.5 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.8 | 4.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.8 | 4.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.8 | 4.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.8 | 3.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.8 | 2.3 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 0.8 | 3.8 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.7 | 5.7 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.7 | 2.8 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.7 | 2.7 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.7 | 2.7 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.7 | 4.0 | GO:0070026 | nitric oxide binding(GO:0070026) |
| 0.7 | 3.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.7 | 2.0 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.6 | 1.9 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.6 | 3.9 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.6 | 2.6 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.6 | 4.5 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.6 | 2.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.6 | 1.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.6 | 1.9 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.6 | 2.5 | GO:0004803 | transposase activity(GO:0004803) |
| 0.6 | 2.4 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.6 | 4.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.6 | 5.9 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.6 | 3.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.6 | 7.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.6 | 2.3 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.6 | 1.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.6 | 2.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.6 | 2.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.6 | 2.3 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.6 | 4.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.6 | 4.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.6 | 2.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.6 | 5.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.6 | 2.8 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.6 | 1.7 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.6 | 2.2 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.6 | 13.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.6 | 2.2 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.5 | 8.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.5 | 2.7 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.5 | 1.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.5 | 1.6 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.5 | 2.6 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.5 | 1.6 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.5 | 2.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.5 | 1.5 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 0.5 | 1.5 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.5 | 1.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.5 | 2.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.5 | 4.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.5 | 1.9 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.5 | 0.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.5 | 2.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.5 | 3.8 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.5 | 2.8 | GO:0008940 | nitrate reductase activity(GO:0008940) |
| 0.5 | 1.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.5 | 1.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.5 | 4.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.5 | 1.9 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.5 | 1.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.5 | 4.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.5 | 1.8 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.5 | 1.4 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.5 | 1.8 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.4 | 3.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.4 | 1.8 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.4 | 1.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.4 | 1.8 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.4 | 3.1 | GO:0042806 | fucose binding(GO:0042806) |
| 0.4 | 1.8 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.4 | 1.3 | GO:0031896 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
| 0.4 | 6.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.4 | 3.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.4 | 6.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.4 | 1.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.4 | 3.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.4 | 2.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.4 | 3.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.4 | 5.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.4 | 1.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.4 | 2.6 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.4 | 1.3 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.4 | 0.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.4 | 1.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.4 | 2.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.4 | 1.7 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.4 | 3.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 5.0 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.4 | 1.3 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.4 | 1.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.4 | 1.2 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.4 | 0.4 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.4 | 1.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.4 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.4 | 1.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.4 | 2.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 0.4 | 3.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.4 | 0.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.4 | 1.2 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.4 | 1.6 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.4 | 4.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.4 | 0.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.4 | 1.6 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.4 | 1.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.4 | 2.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.4 | 12.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.4 | 1.2 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.4 | 2.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.4 | 2.4 | GO:0070905 | serine binding(GO:0070905) |
| 0.4 | 2.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.4 | 1.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.4 | 2.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.4 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.4 | 1.2 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.4 | 1.5 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.4 | 1.5 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.4 | 2.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.4 | 4.1 | GO:0046790 | virion binding(GO:0046790) |
| 0.4 | 1.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.4 | 1.5 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.4 | 2.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.4 | 11.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.4 | 5.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.4 | 3.3 | GO:0043426 | MRF binding(GO:0043426) |
| 0.4 | 2.9 | GO:0035473 | lipase binding(GO:0035473) |
| 0.4 | 1.8 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.4 | 1.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.4 | 2.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.4 | 1.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.4 | 1.4 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.4 | 1.8 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.4 | 1.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.4 | 3.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.4 | 5.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.4 | 1.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.4 | 1.1 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.4 | 1.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.4 | 2.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.3 | 1.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.3 | 2.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 0.7 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.3 | 1.4 | GO:0004644 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.3 | 0.3 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.3 | 4.5 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.3 | 1.7 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.3 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
| 0.3 | 1.7 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.3 | 2.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.3 | 0.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.3 | 6.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.3 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.3 | 1.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.3 | 0.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.3 | 1.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.3 | 1.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.3 | 1.3 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.3 | 2.3 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.3 | 3.2 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.3 | 1.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.3 | 2.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.3 | 2.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.3 | 1.0 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.3 | 2.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.3 | 1.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.3 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.3 | 5.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.3 | 1.3 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.3 | 1.3 | GO:0004449 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.3 | 0.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.3 | 4.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.3 | 0.9 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.3 | 1.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.3 | 0.9 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.3 | 1.5 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.3 | 1.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.3 | 7.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.3 | 3.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.3 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.3 | 4.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 2.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.3 | 1.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.3 | 5.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 3.0 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.3 | 2.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 0.9 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 0.3 | 2.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.3 | 3.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.3 | 0.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.3 | 5.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.3 | 4.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.3 | 2.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 0.6 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.3 | 1.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.3 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.3 | 1.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.3 | 0.8 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.3 | 1.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.3 | 1.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.3 | 0.8 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.3 | 0.8 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
| 0.3 | 0.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.3 | 3.6 | GO:0015288 | porin activity(GO:0015288) |
| 0.3 | 0.8 | GO:0030226 | alpha-2 macroglobulin receptor activity(GO:0016964) apolipoprotein receptor activity(GO:0030226) |
| 0.3 | 2.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.3 | 1.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 1.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.3 | 3.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.3 | 1.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.3 | 1.9 | GO:0070728 | leucine binding(GO:0070728) |
| 0.3 | 1.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.3 | 2.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.3 | 1.9 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.3 | 1.1 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.3 | 0.5 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 1.1 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 0.8 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.3 | 1.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.3 | 0.8 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.3 | 4.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.3 | 2.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.3 | 4.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 0.8 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
| 0.3 | 0.3 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.3 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.3 | 9.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.3 | 2.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.3 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.3 | 2.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.3 | 3.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.3 | 2.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.3 | 2.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.3 | 1.8 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.3 | 0.5 | GO:0046977 | peptide antigen-transporting ATPase activity(GO:0015433) TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 0.3 | 1.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.3 | 0.8 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.3 | 0.8 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.3 | 0.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.3 | 1.0 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.3 | 3.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 1.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.2 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.2 | 0.5 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.2 | 1.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 3.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 5.2 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.2 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.2 | 2.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 0.7 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.2 | 1.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 4.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.2 | 0.7 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.2 | 7.3 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.2 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 4.1 | GO:0043559 | insulin binding(GO:0043559) |
| 0.2 | 19.0 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.2 | 6.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.2 | 1.7 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.2 | 1.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.2 | 2.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 1.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.2 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.2 | 1.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 1.2 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 3.2 | GO:0019864 | IgG binding(GO:0019864) |
| 0.2 | 0.9 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.2 | 0.7 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.2 | 5.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.2 | 6.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 0.9 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.2 | 3.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 3.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.2 | 0.2 | GO:0000406 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.2 | 0.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.2 | 49.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 1.1 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.2 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.2 | 2.2 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.2 | 1.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.2 | 1.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.2 | 3.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 2.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.2 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.2 | 0.9 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.2 | 1.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.2 | 4.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.2 | 1.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.2 | 0.6 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.2 | 2.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 3.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 2.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.2 | 3.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 1.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.2 | 4.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.2 | 1.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.2 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.2 | 1.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.2 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.2 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 2.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.2 | 1.0 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.2 | 0.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 0.8 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.2 | 1.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 4.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.2 | 2.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.2 | 0.2 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
| 0.2 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.2 | 1.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 2.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 3.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.2 | 2.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.2 | 1.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.2 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.2 | 0.6 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.2 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.2 | 0.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.2 | 2.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 7.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 3.0 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.2 | 0.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.2 | 1.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.2 | 0.6 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.2 | 1.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.2 | 2.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 1.9 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 0.2 | 14.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.2 | 3.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 0.8 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.2 | 1.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.2 | 0.6 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.2 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.2 | 0.6 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.2 | 1.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 0.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 2.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 1.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.2 | 3.7 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.2 | 1.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.2 | 11.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 0.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.2 | 1.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.2 | 0.5 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.2 | 0.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.2 | 0.7 | GO:0047977 | linoleate 13S-lipoxygenase activity(GO:0016165) hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.2 | 2.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.2 | 6.7 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.2 | 12.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.2 | 7.8 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 1.4 | GO:0015165 | nucleotide-sugar transmembrane transporter activity(GO:0005338) pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.2 | 0.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.2 | 3.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.2 | 2.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.2 | 1.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.2 | 4.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.2 | 11.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.2 | 0.9 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.2 | 2.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 1.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 3.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.2 | 1.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.2 | 0.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.2 | 1.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.2 | 0.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 4.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.2 | 0.5 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.2 | 5.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 0.5 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.2 | 1.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.2 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.2 | 0.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.2 | 4.0 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.2 | 1.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.2 | 8.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.2 | 2.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.2 | 2.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.2 | 4.0 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.2 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.2 | 1.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.2 | 0.7 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.2 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 1.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 1.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.2 | 1.5 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.2 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.2 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 0.5 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.2 | 0.7 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.2 | 1.0 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.2 | 3.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.2 | 1.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.2 | 5.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.2 | 5.9 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.2 | 3.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.2 | 0.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.2 | 3.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 0.6 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.2 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.2 | 0.5 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.2 | 1.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.2 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.2 | 3.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.2 | 1.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 0.5 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.2 | 2.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.2 | 1.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.2 | 0.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.2 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.2 | 0.5 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.2 | 0.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.2 | 0.6 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.2 | 7.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.3 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
| 0.1 | 0.3 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.1 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 1.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 2.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 2.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 0.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.1 | 11.0 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.1 | 1.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.1 | 9.6 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.1 | 4.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.1 | 4.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 0.6 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
| 0.1 | 2.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.4 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.1 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
| 0.1 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.1 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 10.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.1 | 2.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.6 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
| 0.1 | 0.7 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 0.3 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.1 | 1.4 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 0.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.1 | 3.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 1.0 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
| 0.1 | 1.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 1.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.4 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.1 | 1.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 0.4 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.1 | 0.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 4.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 5.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 2.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 0.8 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.1 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.1 | 11.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.1 | 1.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 14.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 6.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 6.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 1.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 0.9 | GO:0005416 | hydrogen:amino acid symporter activity(GO:0005280) cation:amino acid symporter activity(GO:0005416) |
| 0.1 | 0.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 0.4 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.1 | 1.0 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 1.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 2.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.1 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
| 0.1 | 0.4 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 3.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 0.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.1 | 1.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 0.7 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.1 | 0.2 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.1 | 2.2 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 4.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 0.2 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.1 | 2.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.4 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.1 | 0.5 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.1 | 2.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 0.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.1 | 3.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 0.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.6 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 0.8 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.1 | 0.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.1 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 4.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 2.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.1 | 0.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.1 | 1.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 3.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 6.5 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.1 | 0.5 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.1 | 0.3 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.1 | 3.2 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.1 | 4.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 3.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 1.4 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.1 | 0.3 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.1 | 0.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.1 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.1 | 1.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 1.3 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.1 | 1.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 0.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
| 0.1 | 3.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 1.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 0.3 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.1 | 0.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.1 | 3.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.1 | 0.4 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.1 | 3.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 0.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 0.3 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.1 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 1.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.1 | 1.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 1.3 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 1.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.1 | 0.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.1 | 2.7 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.1 | 4.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 1.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.1 | 1.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.8 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.1 | 2.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.1 | 0.1 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.1 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.1 | 0.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 0.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 4.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.3 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.1 | 1.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 31.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 1.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 1.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.1 | 2.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 0.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 1.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 0.3 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.1 | 0.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 1.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.1 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 3.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 5.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 3.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 3.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 1.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.2 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.1 | 0.4 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.1 | 2.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 2.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.1 | 0.1 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.1 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.1 | 1.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.1 | 1.7 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.1 | 2.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 1.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.1 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.1 | 0.5 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.1 | 0.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 7.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.1 | 2.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.3 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
| 0.1 | 0.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.8 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 4.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.1 | 2.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.1 | 0.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.1 | 0.2 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.1 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.1 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 3.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 2.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
| 0.1 | 1.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 0.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.1 | 1.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 0.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.1 | 0.2 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.1 | 1.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.1 | 3.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 4.5 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.3 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.1 | 0.2 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
| 0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.1 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.1 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 0.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.1 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.3 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 0.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.1 | 2.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 1.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 1.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 1.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 1.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.1 | 0.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.1 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 1.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 1.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 0.3 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.1 | 0.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.1 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.4 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.1 | 2.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 0.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 1.7 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 5.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.1 | 0.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.1 | 0.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.1 | 1.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 3.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 1.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 2.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 1.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 2.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.1 | 2.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.7 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 1.5 | GO:0008026 | ATP-dependent DNA helicase activity(GO:0004003) ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.1 | 0.3 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 0.1 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 1.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.5 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 0.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.1 | 0.5 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.1 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.1 | 8.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
| 0.1 | 0.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.1 | 2.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 1.2 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
| 0.1 | 5.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 0.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 0.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.1 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
| 0.1 | 1.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 1.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 0.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.1 | 11.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 1.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 0.2 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.1 | 7.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 1.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.1 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 0.3 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 2.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 5.4 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.1 | 3.2 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 0.1 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 0.1 | 4.2 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.1 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 0.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.1 | 0.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.4 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.1 | 0.4 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
| 0.1 | 0.9 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.1 | 1.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.1 | 0.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.1 | 0.4 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 1.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.1 | 2.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.0 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.0 | 1.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.0 | 0.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.0 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.0 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.0 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.0 | 2.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.0 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.0 | 17.2 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 13.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.4 | GO:0008237 | metallopeptidase activity(GO:0008237) |
| 0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.0 | 0.0 | GO:0052659 | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
| 0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 2.8 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.0 | 1.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 5.8 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.0 | 8.5 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
| 0.0 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 1.1 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.0 | 0.2 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 1.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 3.6 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.1 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.0 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 0.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.4 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
| 0.0 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.0 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 1.7 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
| 0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.0 | 8.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 3.4 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 4.7 | GO:0003823 | antigen binding(GO:0003823) |
| 0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.0 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.0 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 15.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.0 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.0 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.0 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.1 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 0.7 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 1.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.0 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.0 | 2.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 1.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.1 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.0 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.0 | 0.5 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.0 | 0.2 | GO:0071949 | FAD binding(GO:0071949) |
| 0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.3 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 0.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.2 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
| 0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.0 | 0.1 | GO:0051861 | GPI anchor binding(GO:0034235) glycolipid binding(GO:0051861) |
| 0.0 | 0.5 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.0 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 29.3 | GO:0003723 | RNA binding(GO:0003723) |
| 0.0 | 0.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.9 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 0.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
| 0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.2 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.0 | 0.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 0.2 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.0 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.0 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.0 | 0.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.0 | 0.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 4.9 | GO:0008270 | zinc ion binding(GO:0008270) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 2.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.5 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.5 | 11.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 2.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.3 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.3 | 12.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.3 | 19.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.3 | 19.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.3 | 16.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.3 | 28.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.3 | 16.7 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 13.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.3 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.3 | 5.5 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.3 | 21.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.3 | 6.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.3 | 9.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 7.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 4.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 1.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.2 | 8.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 1.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 1.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.2 | 3.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 25.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 2.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 9.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.2 | 1.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.2 | 7.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.2 | 6.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 3.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.2 | 6.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 1.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 1.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.2 | 10.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 1.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.2 | 16.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.2 | 2.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 6.3 | PID FOXO PATHWAY | FoxO family signaling |
| 0.2 | 11.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 13.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.2 | 19.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 3.4 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 4.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 2.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 2.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 3.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 4.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 4.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 2.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 6.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 4.2 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 2.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 1.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 4.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 7.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 7.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 4.4 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 3.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 3.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 8.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 2.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 1.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 1.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 0.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 5.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 3.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 2.6 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 5.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 2.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 1.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 1.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 9.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 3.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 3.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 2.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 11.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 1.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 2.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 1.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 1.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 2.2 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 1.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 2.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 2.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 1.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 1.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 2.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 2.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 1.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 1.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 3.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 1.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 6.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 2.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.5 | 19.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.5 | 4.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.4 | 8.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.4 | 0.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.4 | 6.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.4 | 16.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.4 | 10.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.4 | 6.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.4 | 10.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.4 | 2.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.4 | 8.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.3 | 14.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 14.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.3 | 6.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 0.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.3 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.3 | 3.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.3 | 9.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.3 | 5.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.3 | 6.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 4.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.3 | 2.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.3 | 12.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.3 | 7.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.3 | 6.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.3 | 3.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.3 | 54.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.3 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.3 | 5.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.3 | 16.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.3 | 6.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 1.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.2 | 4.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 8.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.2 | 13.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.2 | 9.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 5.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.2 | 7.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.2 | 9.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.2 | 11.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.2 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.2 | 3.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 8.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.2 | 8.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.2 | 18.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.2 | 12.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 9.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 10.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 2.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 21.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 5.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 3.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 2.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.2 | 0.6 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.2 | 5.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 1.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 3.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.2 | 6.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 8.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 2.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.2 | 17.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 1.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.2 | 5.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 2.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.2 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 6.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 4.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.2 | 2.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 1.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 0.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.2 | 3.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.2 | 4.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 3.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.2 | 12.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 2.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.2 | 2.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.2 | 10.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 4.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 1.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.2 | 5.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 5.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 6.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 6.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 5.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.2 | 0.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.2 | 1.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.2 | 1.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.2 | 5.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 2.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 2.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.2 | 8.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.2 | 2.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 4.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 4.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 5.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.2 | 4.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.2 | 9.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.2 | 11.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 1.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.2 | 8.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.2 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.2 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.2 | 3.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 2.9 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.1 | 4.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.1 | 10.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 1.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 3.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 0.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.1 | 13.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 4.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 2.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 9.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 5.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 4.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 3.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 6.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 2.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 4.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 1.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 3.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 3.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.1 | 3.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 10.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 3.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 4.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 2.2 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
| 0.1 | 4.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 3.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 10.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 0.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 1.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 0.1 | 2.4 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 4.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 0.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.1 | 3.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.1 | 1.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 2.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 0.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 5.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 1.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 3.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 1.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 1.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 1.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 2.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 1.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 2.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 2.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 2.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 2.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 2.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 1.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 3.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 1.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 0.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 0.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 1.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 1.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 1.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 1.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 3.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 2.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 6.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 0.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 4.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.1 | 1.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 0.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 2.8 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
| 0.1 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 2.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 19.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.0 | 0.7 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
| 0.0 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.0 | 4.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.4 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.0 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 0.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.0 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.0 | 0.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.0 | 4.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.9 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.0 | 1.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 2.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.6 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.0 | 0.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.0 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.0 | 2.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 4.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.3 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
| 0.0 | 1.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |